These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30963107)

  • 1. Modeling Parkinson's disease in midbrain-like organoids.
    Smits LM; Reinhardt L; Reinhardt P; Glatza M; Monzel AS; Stanslowsky N; Rosato-Siri MD; Zanon A; Antony PM; Bellmann J; Nicklas SM; Hemmer K; Qing X; Berger E; Kalmbach N; Ehrlich M; Bolognin S; Hicks AA; Wegner F; Sterneckert JL; Schwamborn JC
    NPJ Parkinsons Dis; 2019; 5():5. PubMed ID: 30963107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.
    Kim H; Park HJ; Choi H; Chang Y; Park H; Shin J; Kim J; Lengner CJ; Lee YK; Kim J
    Stem Cell Reports; 2019 Mar; 12(3):518-531. PubMed ID: 30799274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-content phenotyping of Parkinson's disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification.
    Vuidel A; Cousin L; Weykopf B; Haupt S; Hanifehlou Z; Wiest-Daesslé N; Segschneider M; Lee J; Kwon YJ; Peitz M; Ogier A; Brino L; Brüstle O; Sommer P; Wilbertz JH
    Stem Cell Reports; 2022 Oct; 17(10):2349-2364. PubMed ID: 36179692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.
    Smits LM; Schwamborn JC
    Front Cell Dev Biol; 2020; 8():359. PubMed ID: 32509785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
    Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
    Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
    Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
    Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified Brain Organoids for Rapid and Robust Modeling of Brain Disease.
    Ha J; Kang JS; Lee M; Baek A; Kim S; Chung SK; Lee MO; Kim J
    Front Cell Dev Biol; 2020; 8():594090. PubMed ID: 33195269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D Cultures of Parkinson's Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing.
    Bolognin S; Fossépré M; Qing X; Jarazo J; Ščančar J; Moreno EL; Nickels SL; Wasner K; Ouzren N; Walter J; Grünewald A; Glaab E; Salamanca L; Fleming RMT; Antony PMA; Schwamborn JC
    Adv Sci (Weinh); 2019 Jan; 6(1):1800927. PubMed ID: 30643711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression.
    Zagare A; Barmpa K; Smajic S; Smits LM; Grzyb K; Grünewald A; Skupin A; Nickels SL; Schwamborn JC
    Am J Hum Genet; 2022 Feb; 109(2):311-327. PubMed ID: 35077669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Evaluation of Parkinson's Disease Patient-Derived Midbrain Organoids Using Mesoporous Au Nanodot-Patterned 3D Concave Electrode.
    An J; Shin M; Beak G; Yoon J; Kim S; Cho HY; Choi JW
    ACS Sens; 2024 Jul; 9(7):3573-3580. PubMed ID: 38954790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.
    Monzel AS; Smits LM; Hemmer K; Hachi S; Moreno EL; van Wuellen T; Jarazo J; Walter J; Brüggemann I; Boussaad I; Berger E; Fleming RMT; Bolognin S; Schwamborn JC
    Stem Cell Reports; 2017 May; 8(5):1144-1154. PubMed ID: 28416282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired neuron differentiation in GBA-associated Parkinson's disease is linked to cell cycle defects in organoids.
    Rosety I; Zagare A; Saraiva C; Nickels S; Antony P; Almeida C; Glaab E; Halder R; Velychko S; Rauen T; Schöler HR; Bolognin S; Sauter T; Jarazo J; Krüger R; Schwamborn JC
    NPJ Parkinsons Dis; 2023 Dec; 9(1):166. PubMed ID: 38110400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling.
    Kwak TH; Kang JH; Hali S; Kim J; Kim KP; Park C; Lee JH; Ryu HK; Na JE; Jo J; Je HS; Ng HH; Kwon J; Kim NH; Hong KH; Sun W; Chung CH; Rhyu IJ; Han DW
    Stem Cells; 2020 Jun; 38(6):727-740. PubMed ID: 32083763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
    Renner H; Schöler HR; Bruder JM
    Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons.
    Qing X; Walter J; Jarazo J; Arias-Fuenzalida J; Hillje AL; Schwamborn JC
    Stem Cell Res; 2017 Oct; 24():44-50. PubMed ID: 28826027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.
    Howlett EH; Jensen N; Belmonte F; Zafar F; Hu X; Kluss J; Schüle B; Kaufman BA; Greenamyre JT; Sanders LH
    Hum Mol Genet; 2017 Nov; 26(22):4340-4351. PubMed ID: 28973664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.